Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cholesterol Trafficking in the Mouse Embryo Is Regulated by a snoRNA

By LabMedica International staff writers
Posted on 01 Jul 2015
Cellular cholesterol trafficking in mouse embryos was found to be regulated by U17 snoRNA.

Small nucleolar RNAs (snoRNAs) are a class of small RNA molecules that primarily guide chemical modifications of other RNAs, mainly ribosomal RNAs, transfer RNAs and small nuclear RNAs. More...
There are two main classes of snoRNA, the C/D box snoRNAs, which are associated with methylation, and the H/ACA box snoRNAs, which are associated with pseudouridylation. Pseudouridine is the C-glycoside isomer of the nucleoside uridine, and it is the most prevalent of the over one hundred different modified nucleosides found in RNA

Investigators at Washington University School of Medicine (St. Louis, MO, USA) used a loss-of-function screening test to look for Chinese hamster ovary cell mutants with defects in intracellular cholesterol trafficking. They isolated a mutant with haploinsufficiency of U17 snoRNA. U17 is an H/ACA orphan snoRNA, for which a function other than ribosomal processing had not previously been identified.

The investigators published results in the June 2, 2015, issue of the journal Cell Metabolism revealing that through expression profiling they had identified HUMMR (hypoxia-upregulated mitochondrial movement regulator) mRNA as a target that was negatively regulated by U17 snoRNA. In experiments conducted on U17 snoRNA-deficient cells, they found that upregulation of HUMMR promoted the formation of ER (endoplasmic reticulum)-mitochondrial contacts, decreasing esterification of cholesterol, and facilitating cholesterol trafficking to mitochondria.

In contrast, in cells that had an abundance of U17 snoRNA, cholesterol was not transported to the mitochondria, and without this raw material, the cells could not synthesize any steroids.

These findings relating to interactions at the molecular level confirmed previous observations that at birth, mice have high levels of U17 snoRNA, which gradually decline as the animals grow and mature. When the mice reach sexual maturity—at about eight weeks—U17 snoRNA levels have fallen, which increases production of steroid hormones.

"The ovaries need to make steroids to support pregnancy when the mice reach sexual maturation. So we think this small RNA is at least one of the regulators of the processes that govern when a mouse becomes fertile," said senior author Dr. Daniel S. Ory, professor of medicine at the Washington University School of Medicine. "This is one of several hundred snoRNAs. Clearly, some of them have functions beyond the traditional understanding of snoRNAs, and perhaps they should be studied more systematically."

Related Links:

Washington University School of Medicine



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.